Project 4-Treatment of Bronchial Asthma with Borage Seed

项目4-琉璃苣籽治疗支气管哮喘

• 批准号: 6946088
• 负责人: Jonathan Peter Arm
• 金额: $ 37.55万
• 依托单位: WAKE FOREST UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-02-01 至 2010-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6946088
• 关键词: alternative medicine; angiosperms; arachidonate; asthma; clinical trial phase II; diet therapy; dietary lipid; dietary supplements; fatty acid biosynthesis; human subject; human therapy evaluation; linolenate; nutrition related tag; omega 3 fatty acid; patient oriented research; personal log /diary; plant extracts; spirometry; vegetable oils

Asthma affects about 20 million Americans, results in annual direct and indirect health care costs of approximately $8 billion, and its incidence has doubled in the last decade. Morbidity and mortality from the disease has risen proportionally and is especially prevalent among minority individuals. There is a growing demand for alternative and complementary treatments for this common disease. Leukotrienes are important in the pathogenesis of asthma, and leukotriene modifying drugs are now an established treatment for the disease. Drugs that inhibit the biosynthesis of leukotrienes are likely to more effective than the currently available drugs that antagonize a single leukotriene receptor. Dietary supplementation with gamma linolenic acid (GLA) in borage seed oil provides effective inhibition of leukotriene generation but also increases circulating free arachidonic acid (AA), which has pro-inflammatory potential. The n-3 fatty acid, eicosapentaenoic acid (EPA), prevented the conversion of GLA to AA. However, EPA is extracted from fish oil, is not well-tolerated due to its taste, and at higher doses appeared to blunt the inhibition of leukotriene biosynthesis by GLA. Stearidonic acid (SDA), is a precursor of EPA that is extracted from Echium Plantagineum; it is converted to EPA in humans and it does not have the organoleptic properties of EPA. In Specific Aim 1 we will test the hypothesis that SDA prevents the conversion of GLA to AA while maintaining effective inhibition of leukotriene biosynthesis, In Specific Aim 2 we will test the hypothesis that borage seed oil combined with echium seed oil is an effective treatment of mild to moderate persistent asthma. This Project is synergistic with Project 3 which examines the cellular and molecular anti-inflammatory mechanisms of GLA. It is synergistic with Project 2, which examines the effects and mechanisms of action of SDA in atherosclerosis. The integrated results will provide a solid scientific underpinning for future studies of these botanical oils in these and other chronic inflammatory disease.

哮喘影响了大约2000万美国人，每年的直接和间接医疗费用约为80亿美元，其发病率在过去十年中翻了一番。该疾病的发病率和死亡率呈比例上升，在少数民族人群中尤为普遍。对这种常见疾病的替代和补充治疗的需求日益增长。白三烯在哮喘的发病机制中很重要，白三烯修饰药物现在是一种确定的治疗哮喘的药物。抑制白三烯生物合成的药物可能比目前可用的拮抗单一白三烯受体的药物更有效。膳食补充γ -亚麻酸